Evaluation of the peri-strut low intensity area following sirolimus- and paclitaxel-eluting stents implantation: Insights from an optical coherence tomography study in humans (original) (raw)

OCT-Verified Peri-Strut Low-Intensity Areas and the Extent of Neointimal Formation After 3 Years Following Stent Implantation

Hyeon-cheol Gwon

JACC: Cardiovascular Imaging, 2012

View PDFchevron_right

Comparison of Neointimal Coverage by Optical Coherence Tomography of a Sirolimus-Eluting Stent Versus a Bare-Metal Stent Three Months After Implantation

Kyoichi Mizuno

The American Journal of Cardiology, 2008

View PDFchevron_right

ComparisOn of neointimal coVerage betwEen zotaRolimus-eluting stent and everolimus-eluting stent using Optical Coherence Tomography (COVER OCT)

Chang-wook Nam

American Heart Journal, 2012

View PDFchevron_right

Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography

francis ma

Heart, 2008

View PDFchevron_right

Local Determinants of Thrombus Formation Following Sirolimus-Eluting Stent Implantation Assessed by Optical Coherence Tomography

Junya Shite

JACC: Cardiovascular Interventions, 2009

View PDFchevron_right

Impact of different stent alloys on human vascular response to everolimus-eluting stent: An optical coherence tomography study: The OCTEVEREST

orazio valsecchi

Catheterization and Cardiovascular Interventions, 2013

View PDFchevron_right

Clinical significance of low signal intensity area surrounding stent struts identified by optical coherence tomography

Takashi Akasaka

International heart journal, 2013

View PDFchevron_right

The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography

Carlo Di Mario

International Journal of Cardiology, 2009

View PDFchevron_right

Optical coherence tomography evaluation of intermediate-term healing of different stent types: systemic review and meta-analysis

giovanni marchelli

View PDFchevron_right

Nonuniform Strut Distribution Correlates With More Neointimal Hyperplasia After Sirolimus-Eluting Stent Implantation

Ricardo Costa

2010

View PDFchevron_right

Analysis of Long-term Arterial Healing Following Implantation of Different Types of Stents by Optical Coherence Tomography

Junya Shite, Tsuyoshi Osue

Canadian Journal of Cardiology, 2014

View PDFchevron_right

Different patterns of neointimal coverage between acute coronary syndrome and stable angina after various types of drug-eluting stents implantation; 9-month follow-up optical coherence tomography study

Namsik Chung

International Journal of Cardiology, 2011

View PDFchevron_right

Effect of strut thickness on neointimal atherosclerotic change over an extended follow-up period (≥4 years) after bare-metal stent implantation: Intracoronary optical coherence tomography examination

Takashi Akasaka

American Heart Journal, 2012

View PDFchevron_right

Evaluation by Optical Coherence Tomography of Neointimal Coverage of Sirolimus-Eluting Stent Three Months After Implantation

Kyoichi Mizuno

The American Journal of Cardiology, 2007

View PDFchevron_right

Vascular response after implantation of biolimus A9-eluting stent with bioabsorbable polymer and everolimus-eluting stents with durable polymer. Results of the optical coherence tomography analysis of the BIOACTIVE randomized trial

Daniel Chamié

Revista Brasileira de Cardiologia Invasiva (English Edition), 2015

View PDFchevron_right

Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: An optical coherence tomography study

Vasileios Karantalis

International Journal of Cardiology, 2011

View PDFchevron_right

Angioscopic differences in neointimal coverage and in persistence of thrombus between sirolimus-eluting stents and bare metal stents after a 6-month implantation

Shigenobu Inami

European Heart Journal, 2006

View PDFchevron_right

Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography

Junya Shite

European Heart Journal, 2007

View PDFchevron_right

STACCATO (Assessment of Stent sTrut Apposition and Coverage in Coronary ArTeries with Optical coherence tomography in patients with STEMI, NSTEMI and stable/unstable angina undergoing everolimus vs. biolimus A9-eluting stent implantation): a randomised controlled trial

Tom Adriaenssens, Walter Desmet

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2014

View PDFchevron_right

Randomized comparison of biolimus-eluting stents with biodegradable polymer versus everolimus-eluting stents with permanent polymer coatings assessed by optical coherence tomography

Tomohisa Tada

The International Journal of Cardiovascular Imaging, 2014

View PDFchevron_right

Comparative analysis of neointimal coverage with paclitaxel and zotarolimus drug-eluting stents, using optical coherence tomography 6 months after implantation

Laurent Sarry

Archives of Cardiovascular Diseases, 2009

View PDFchevron_right

Pathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in Humans

Marc Vorpahl

Circulation, 2014

View PDFchevron_right

An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study

Pedro Eerdmans

European Heart Journal, 2010

View PDFchevron_right

Early coverage of drug-eluting stents analysed by optical coherence tomography: evidence of the impact of stent apposition and strut characteristics on the neointimal healing process

Renick Lee

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2016

View PDFchevron_right

Serial Assessment by Optical Coherence Tomography of Early and Late Vascular Responses After Implantation of an Absorbable-Coating Sirolimus-Eluting Stent (from the First-in-Human DESSOLVE I Trial)

John Ormiston

The American Journal of Cardiology, 2013

View PDFchevron_right